据知情人士透露，美国总统特朗普政府最早将于当地时间周四，对尚未达成确保在美国低价销售协议的制药商征收关税，这是其以国家安全为由对进口商品征税的最新举措。
过去一年来，特朗普一直威胁要对制药行业征收关税，税率可能在100%至200%之间，旨在迫使制药公司将制造业迁回美国，并降低美国患者的药价。包括辉瑞公司和礼来公司在内的多数大型制药公司已与白宫达成协议，以换取此类关税为期三年的豁免。
知情人士表示，新关税源于根据《1962年贸易扩展法》第232条款进行的调查。尚未达成协议且未与政府进行谈判的公司将面临100%的关税。
知情人士称，计划尚未最终确定，仍可能有变。他们表示，某些药物和疾病类别也可能获得豁免。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.